You just have to appreciate at the moment that OSL is a binary situation. If it gets CE Mark approval over the next few days or advice to that effect then this will go for a run. If it doesn't get approval then you will see this back down 4 cents. Currently it is no more than a bet on approval. And while CE mark is probably easier than FDA they aren't pushovers so don't be surprised to see them ask for more information - with a 9 month delay attached. Talk about when sales will begin and is it for sale in Australia yet is really getting the cart before the horse.
I have held for years and would love to see it achieve but also held TIS which suffered greatly at the EMA process.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)